01 15AstraZeneca Canada Inc.
01 22388818
02 72402894
03 22486539
04 42568391
01 8SAXAGLIPTIN HYDROCHLORIDE | DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
02 4Saxagliptin Hydrochloride
03 3Saxagliptin Hydrochloride | Metformin Hydrochloride
01 8TABLET
02 7Tablet
01 22020-10-02
02 72021-03-05
03 22023-05-15
04 42025-05-26
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Saxagliptin Hydrochloride, Metformin
Brand Name : KOMBOGLYZE
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg / 850 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Saxagliptin Hydrochloride, Metformin
Brand Name : KOMBOGLYZE
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg / 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Saxagliptin Hydrochloride, Metformin
Brand Name : KOMBOGLYZE
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg / 1000 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Brand Name : ONGLYZA
Patent Number : 2568391
Filing Date : 2005-05-26
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Brand Name : ONGLYZA
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Brand Name : ONGLYZA
Patent Number : 2568391
Filing Date : 2005-05-26
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Brand Name : ONGLYZA
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Saxagliptin Hydrochloride, Dapagliflozin Propanediol Monohydrate
Brand Name : QTERN
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 5mg / 5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Saxagliptin Hydrochloride, Dapagliflozin Propanediol Monohydrate
Brand Name : QTERN
Patent Number : 2568391
Filing Date : 2005-05-26
Strength per Unit : 5mg / 5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-05-26
Date Granted : 2013-05-14
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
Saxagliptin Hydrochloride, Dapagliflozin Propanediol Monohydrate
Brand Name : QTERN
Patent Number : 2486539
Filing Date : 2003-05-15
Strength per Unit : 5mg / 5mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
